{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:50:22Z","timestamp":1787028622590,"version":"build-2736575974"},"reference-count":57,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T00:00:00Z","timestamp":1643068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["1R42EY029625-01"],"award-info":[{"award-number":["1R42EY029625-01"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Age-related macular degeneration (AMD) is a leading cause of irreversible blindness in the developed world. While great advances have been made in the treatment of the neovascular (\u201cwet\u201d) form of the disease, there is still a significant need for therapies that prevent the vision loss associated with the advanced forms of dry, atrophic AMD. In this atrophic form, retinal pigment epithelial (RPE) and photoreceptor cell death is the ultimate cause of vision loss. In this review, we summarize the cell death pathways and their relation to RPE and retinal cell death in AMD. We review the data that support targeting programmed cell death through inhibition of the Fas receptor as a novel approach to preserve these structures and that this effect results from inhibiting both canonical death pathway activation and reducing the associated inflammatory response. These data lay the groundwork for current clinical strategies targeting the Fas pathway in this devastating disease.<\/jats:p>","DOI":"10.3390\/jcm11030592","type":"journal-article","created":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T20:40:18Z","timestamp":1643143218000},"page":"592","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Cell Death in AMD: The Rationale for Targeting Fas"],"prefix":"10.3390","volume":"11","author":[{"given":"David N.","family":"Zacks","sequence":"first","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor, MI 48105, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6069-2166","authenticated-orcid":false,"given":"Andrew J.","family":"Kocab","sequence":"additional","affiliation":[{"name":"ONL Therapeutics, Inc., Ann Arbor, MI 48104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne J.","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor, MI 48105, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith S.","family":"Gregory-Ksander","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Schepens Eye Research Institute, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA 02114, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisol","family":"Cano","sequence":"additional","affiliation":[{"name":"Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD 21287, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T.","family":"Handa","sequence":"additional","affiliation":[{"name":"Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD 21287, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/archopht.122.4.564","article-title":"Prevalence of Age-Related Macular Degeneration in the United States","volume":"122","author":"Friedman","year":"2004","journal-title":"Arch. Ophthalmol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ophtha.2004.10.047","article-title":"Risk Factors for the Incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS): AREDS report no. 19","volume":"112","author":"Clemons","year":"2005","journal-title":"Ophthalmology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00055735-200206000-00007","article-title":"Risk factors for age-related macular degeneration: An update","volume":"13","author":"Hyman","year":"2002","journal-title":"Curr. Opin. Ophthalmol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1001\/archopht.123.11.1570","article-title":"A simplified severity scale for age-related macular degeneration: AREDS report no. 18","volume":"123","author":"Ferris","year":"2005","journal-title":"Arch. Ophthalmol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Halawa, O.A., Lin, J.B., Miller, J.W., and Vavvas, D.G. (2021). A Review of Completed and Ongoing Complement Inhibitor Trials for Geographic Atrophy Secondary to Age-Related Macular Degeneration. J. Clin. Med., 10.","DOI":"10.3390\/jcm10122580"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s40259-021-00481-y","article-title":"Investigational Agents in Development for the Treatment of Geographic Atrophy Secondary to Age-Related Macular Degeneration","volume":"35","author":"Hannah","year":"2021","journal-title":"BioDrugs"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/ICU.0000000000000746","article-title":"Emerging treatments for geographic atrophy in age-related macular degeneration","volume":"32","author":"Mahmoudzadeh","year":"2021","journal-title":"Curr. Opin. Ophthalmol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0092-8674(00)81873-5","article-title":"Programmed Cell Death in Animal Development","volume":"88","author":"Jacobson","year":"1997","journal-title":"Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ymeth.2007.12.001","article-title":"Apoptosis and necrosis: Detection, discrimination and phagocytosis","volume":"44","author":"Krysko","year":"2008","journal-title":"Methods"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ymeth.2013.02.011","article-title":"Determination of apoptotic and necrotic cell death in vitro and in vivo","volume":"61","author":"Grootjans","year":"2013","journal-title":"Methods"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nchembio711","article-title":"Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury","volume":"1","author":"Degterev","year":"2005","journal-title":"Nat. Chem. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Ketelut-Carneiro, N., and Fitzgerald, K.A. (2021). Apoptosis, pyroptosis, and necroptosis\u2014Oh my! The many ways a cell can die. J. Mol. Biol., 167378.","DOI":"10.1016\/j.jmb.2021.167378"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/82732","article-title":"Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule","volume":"1","author":"Holler","year":"2000","journal-title":"Nat. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: Recommendations of the Nomenclature Committee on Cell Death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death Differ."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0966-842X(00)01936-3","article-title":"Pro-inflammatory programmed cell death","volume":"9","author":"Cookson","year":"2001","journal-title":"Trends Microbiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrmicro2070","article-title":"Pyroptosis: Host cell death and inflammation","volume":"7","author":"Bergsbaken","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.cell.2020.04.039","article-title":"SnapShot: Ferroptosis","volume":"181","author":"Hadian","year":"2020","journal-title":"Cell"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Shu, W., and Dunaief, J.L. (2018). Potential Treatment of Retinal Diseases with Iron Chelators. Pharmaceuticals, 11.","DOI":"10.3390\/ph11040112"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.neuron.2012.06.018","article-title":"Mechanisms of Age-Related Macular Degeneration","volume":"75","author":"Ambati","year":"2012","journal-title":"Neuron"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1755-3768.2011.02179.x","article-title":"Molecular mechanisms of retinal pigment epithelium damage and development of age-related macular degeneration","volume":"90","author":"Kinnunen","year":"2012","journal-title":"Acta Ophthalmol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.arr.2015.09.002","article-title":"RPE necroptosis in response to oxidative stress and in AMD","volume":"24","author":"Hanus","year":"2015","journal-title":"Ageing Res. Rev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"16054","DOI":"10.1038\/cddiscovery.2016.54","article-title":"Retinal pigment epithelial cell necroptosis in response to sodium iodate","volume":"2","author":"Hanus","year":"2016","journal-title":"Cell Death Discov."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1001\/archopht.120.11.1435","article-title":"The Role of Apoptosis in Age-Related Macular Degeneration","volume":"120","author":"Dunaief","year":"2002","journal-title":"Arch. Ophthalmol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1167\/iovs.12-10849","article-title":"Inflammatory Mediators Induced by Amyloid-Beta in the Retina and RPE In Vivo: Implications for Inflammasome Activation in Age-Related Macular Degeneration","volume":"54","author":"Liu","year":"2013","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1167\/iovs.12-10655","article-title":"NLRP3 Inflammasome Activation in Retinal Pigment Epithelial Cells by Lysosomal Destabilization: Implications for Age-Related Macular Degeneration","volume":"54","author":"Tseng","year":"2013","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jphotobiol.2016.05.018","article-title":"Inflammasome priming increases retinal pigment epithelial cell susceptibility to lipofuscin phototoxicity by changing the cell death mechanism from apoptosis to pyroptosis","volume":"161","author":"Brandstetter","year":"2016","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12974-018-1062-3","article-title":"Evidence for the activation of pyroptotic and apoptotic pathways in RPE cells associated with NLRP3 inflammasome in the rodent eye","volume":"15","author":"Gao","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ophtha.2020.08.027","article-title":"C5 inhibitor avacincaptad pegol for geographic atrophy due to age-related macular degeneration: A randomized pivotal phase 2\/3 trial","volume":"128","author":"Jaffe","year":"2021","journal-title":"Ophthalmology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ophtha.2019.07.011","article-title":"Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial","volume":"127","author":"Liao","year":"2020","journal-title":"Ophthalmology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1159\/000517794","article-title":"The Use of Neuroprotective Agents in Treating Geographic Atrophy","volume":"64","author":"Scholl","year":"2021","journal-title":"Ophthalmic Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.preteyeres.2013.08.001","article-title":"Photoreceptor cell death and rescue in retinal detachment and degenerations","volume":"37","author":"Murakami","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/IIO.0b013e31829cf08d","article-title":"Neuroprotection for Retinal Detachment","volume":"53","author":"Huckfeldt","year":"2013","journal-title":"Int. Ophthalmol. Clin."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1056\/NEJM199606273342607","article-title":"The Tumor Necrosis Factor Ligand and Receptor Families","volume":"334","author":"Bazzoni","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0163-7258(00)00096-6","article-title":"Death the Fas way: Regulation and pathophysiology of CD95 and its ligand","volume":"88","author":"Sharma","year":"2000","journal-title":"Pharmacol. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.it.2018.10.005","article-title":"FADD at the Crossroads between Cancer and Inflammation","volume":"39","author":"Mouasni","year":"2018","journal-title":"Trends Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/febs.14292","article-title":"Nonapoptotic functions of Fas\/ CD 95 in the immune response","volume":"285","author":"Legembre","year":"2018","journal-title":"FEBS J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1167\/iovs.04-0598","article-title":"FAS-Mediated Apoptosis and Its Relation to Intrinsic Pathway Activation in an Experimental Model of Retinal Detachment","volume":"45","author":"Zacks","year":"2004","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1001\/archopht.125.10.1389","article-title":"Role of the Fas-Signaling Pathway in Photoreceptor Neuroprotection","volume":"125","author":"Zacks","year":"2007","journal-title":"Arch. Ophthalmol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Besirli, C.G., Zheng, Q.-D., Reed, D.M., and Zacks, D.N. (2012). ERK-Mediated Activation of Fas Apoptotic Inhibitory Molecule 2 (Faim2) Prevents Apoptosis of 661W Cells in a Model of Detachment-Induced Photoreceptor Cell Death. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0046664"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1038\/cdd.2017.109","article-title":"FAS apoptotic inhibitory molecule 2 is a stress-induced intrinsic neuroprotective factor in the retina","volume":"24","author":"Pawar","year":"2017","journal-title":"Cell Death Differ."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1167\/iovs.16-21392","article-title":"Protective Effect of Met12, a Small Peptide Inhibitor of Fas, on the Retinal Pigment Epithelium and Photoreceptor After Sodium Iodate Injury","volume":"58","author":"Xiao","year":"2017","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12974-019-1576-3","article-title":"A small peptide antagonist of the Fas receptor inhibits neuroinflammation and prevents axon degeneration and retinal ganglion cell death in an inducible mouse model of glaucoma","volume":"16","author":"Krishnan","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1167\/iovs.07-0308","article-title":"Associations of Plasma-Soluble Fas Ligand with Aging and Age-Related Macular Degeneration","volume":"49","author":"Jiang","year":"2008","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.freeradbiomed.2014.01.015","article-title":"Nrf2 signaling modulates cigarette smoke-induced complement activation in retinal pigmented epithelial cells","volume":"70","author":"Wang","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2014.01.004","article-title":"Oxidative stress induces mitochondrial dysfunction and a protective unfolded protein response in RPE cells","volume":"69","author":"Cano","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41572-021-00265-2","article-title":"Age-related macular degeneration","volume":"7","author":"Fleckenstein","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Spindler, J., Zandi, S., Pfister, I.B., Gerhardt, C., and Garweg, J.G. (2018). Cytokine profiles in the aqueous humor and serum of patients with dry and treated wet age-related macular degeneration. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0203337"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1167\/iovs.61.4.28","article-title":"Chemokine Profile and the Alterations in CCR5-CCL5 Axis in Geographic Atrophy Secondary to Age-Related Macular Degeneration","volume":"61","author":"Nielsen","year":"2020","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000446587","article-title":"Association of Choroidal Interleukin-17-Producing T Lymphocytes and Macrophages with Geographic Atrophy","volume":"236","author":"Camelo","year":"2016","journal-title":"Ophthalmologica"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nri3459","article-title":"Immunology of age-related macular degeneration","volume":"13","author":"Ambati","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1073\/pnas.0408835103","article-title":"Drusen complement components C3a and C5a promote choroidal neovascularization","volume":"103","author":"Nozaki","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.molcel.2013.01.025","article-title":"Fas\/CD95-Induced Chemokines Can Serve as \u201cFind-Me\u201d Signals for Apoptotic Cells","volume":"49","author":"Cullen","year":"2013","journal-title":"Mol. Cell"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12974-015-0389-2","article-title":"HMGB1 release triggered by the interaction of live retinal cells and uveitogenic T cells is Fas\/FasL activation-dependent","volume":"12","author":"Jiang","year":"2015","journal-title":"J. Neuroinflamm."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1084\/jem.191.7.1209","article-title":"Opposing Effects of Transmembrane and Soluble FAS Ligand Expression on Inflammation and Tumor Cell Survival","volume":"191","author":"Hohlbaum","year":"2000","journal-title":"J. Exp. Med."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Gregory, M.S., Hackett, C.G., Abernathy, E.F., Lee, K.S., Saff, R.R., Hohlbaum, A.M., Moody, K.-S.L., Hobson, M.W., Jones, A., and Kolovou, P. (2011). Opposing Roles for Membrane Bound and Soluble Fas Ligand in Glaucoma-Associated Retinal Ganglion Cell Death. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0017659"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.4049\/jimmunol.1601488","article-title":"Overexpression of Soluble Fas Ligand following Adeno-Associated Virus Gene Therapy Prevents Retinal Ganglion Cell Death in Chronic and Acute Murine Models of Glaucoma","volume":"197","author":"Krishnan","year":"2016","journal-title":"J. Immunol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/3\/592\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:07:11Z","timestamp":1760134031000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/3\/592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,25]]},"references-count":57,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["jcm11030592"],"URL":"https:\/\/doi.org\/10.3390\/jcm11030592","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,25]]}}}